New Sample Preparation Solution Simplifies Food Safety Testing
December 9, 2021
The Thermo Scientific QuEChERS portfolio delivers robust, sensitive quantitation in compliance with global regulatory requirements LANGERWEHE, Germany – Food industry, government and contract testing laboratories performing food safety analysis can now benefit from a new portfolio that offers cost-effective, robust Solid-Phase Extraction (SPE) solutions to support food safety workflows and meet regulatory requirements across Europe, [...]
HTG Announces Major Sales Milestone for HTG Transcriptome Panel
December 9, 2021
TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that it has exceeded $1 million of revenue recognized from sales of its HTG Transcriptome Panel (HTP) as of November 30, 2021. HTP was launched with commercial availability in the United [...]
Illumina Supports Norway’s Pioneering Precision Medicine Study
December 9, 2021
Study to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN), today announced that it is supporting a national precision medicine study in Norway to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing. The study will also evaluate [...]
December 9, 2021
Oncomine Dx Target Test now approved for 12 NSCLC targeted therapies globally CARLSBAD, Calif. -- The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Target Test as a companion diagnostic (CDx) to help identify non-small cell lung cancer (NSCLC) patients whose tumors carry epidermal growth factor receptor (EGFR) Exon20-insertion mutations for potential [...]
December 9, 2021
Dr. David Ledbetter Named Chief Clinical and Research Officer of UPN BOSTON – Seven Bridges Genomics, the industry-leading bioinformatics ecosystem provider, today announced the formation of a new subsidiary, the Unified Patient Network (UPN), to facilitate clinical research and collaboration between participating health systems and biopharma companies with a focus on advancing precision medicine and improving [...]
Two New FE-SEM Models Launched to Support Data-Driven R&D
December 9, 2021
Improved automatic acquisition of large volumes of data contributes to increased throughput Tokyo – Hitachi High-Tech Corporation ("Hitachi High-Tech") announced today the launch of two cutting-edge FE-SEM*1 models, the SU8600 and SU8700 (hereinafter, "this product line"), that feature new detectors, capabilities, advanced automation, and more. This class of instrumentation is used to observe, measure, define and [...]
Maravai LifeSciences Announces Establishment of New Charitable Foundation
December 9, 2021
Maravai LifeSciences Foundation to support STEM, scientific education, community health, and COVID response SAN DIEGO -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced it is establishing a new charitable foundation to promote causes tied to Maravai’s mission. The Maravai [...]
Cardea Bio accelerates commercial platform due to demand from market moving partners
December 9, 2021
SAN DIEGO -- To signal that Cardea Bio, Inc. is investing significantly into the commercialization efforts of its brand new BPU™ (Biosignal Processing Unit) platform, Cardea is now unveiling a new logo, a new visual identity, a new website, and an updated focus on its core as a biocompatible semiconductor company, including establishing a new business unit [...]
December 9, 2021
Dr. David Ledbetter Named Chief Clinical and Research Officer of UPN BOSTON – Seven Bridges Genomics, the industry-leading bioinformatics ecosystem provider, today announced the formation of a new subsidiary, the Unified Patient Network (UPN), to facilitate clinical research and collaboration between participating health systems and biopharma companies with a focus on advancing precision medicine and improving [...]
Resolve Biosciences Joins EMBL’s Corporate Partnership Programme
December 9, 2021
Single-cell spatial analysis pioneer continues to invest in initiatives that train and support the next generation of molecular life scientists MONHEIM AM RHEIN, Germany – Resolve Biosciences, the pioneer in Molecular Cartography™, today announced a corporate partnership with the European Molecular Biology Laboratory (EMBL). As part of the EMBL’s Corporate Partnership Programme (CPP), Resolve Biosciences [...]

